Skip to main content

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 05 10 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Atos positioned as a Leader in cybersecurity solutions and services in the 2026 ISG Provider Lens™ report for France

Press Release Atos positioned as a Leader in cybersecurity solutions and services in the 2026 ISG Provider Lens™ report for France Paris, France – October 6, 2026 – Atos, a global leader of AI-powered digital transformation, today announced that it has been positioned as a Leader in three strategic segments of the 2026 ISG Provider Lens™ report on cybersecurity solutions and services in France: Next-Gen SOC/MDR Services, Strategic Security Services and Technical Security Services. Organizations are facing increasingly sophisticated, unpredictable and difficult-to-contain cyberattacks across complex cloud and hybrid environments. Growing regulatory compliance requirements present an additional challenge. In this context, according to ISG, standalone security tools are no longer sufficient, and organizations need to implement...

Continue reading

Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its innovative CARTIHEAL AGILI-C Cartilage Repair Implant is now commercially available in Europe. The CARTIHEAL Implant will take center stage at this week’s International Cartilage Regeneration & Joint Preservation Society (ICRS) Summit in Porto, Portugal from October 8-10. Introduced by Smith+Nephew in the US during 2024, the CARTIHEAL Implant is rapidly transforming the cartilage repair landscape. Composed of aragonite, a naturally occurring calcium carbonate acting as a biphasic scaffold, the implant is able to repair cartilage, restore bone, and relieve pain.1–5,* These unique properties enable physicians to surgically treat patients who previously had no access to cartilage repair procedures.1,4,5 Click here to play video Compelling...

Continue reading

Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l’innovativo impianto per la riparazione della cartilagine, che sarà presentato all’ICRS Summit in Portogallo.

Smith+Nephew (LSE: SN, NYSE: SNN) azienda di tecnologia medica, annuncia il lancio commerciale in Europa di CARTIHEAL AGILI-C, l’innovativo impianto per la riparazione della cartilagine. La tecnologia sarà presentata all’International Cartilage Regeneration & Joint Preservation Society (ICRS) Summit, che si terrà a Porto, in Portogallo, dall’8 al 10 ottobre. Introdotto negli Stati Uniti nel 2024, CARTIHEAL AGILI-C di Smith+Nephew nel panorama della riparazione della cartillagine. Composto da aragonite, un materiale naturale a base di carbonato di calcio, l’impianto agisce come scaffold bifasico favorendo la rigenerazione della cartilagine e dell’osso e contribuendo alleviando il dolore.¹⁻⁵ Questa tecnologia amplia l’accesso alle procedure di riparazione della cartilagine, consentendo di trattare chirurgicamente pazienti che in passato...

Continue reading

VirTra Wins Five-Year CBP Contract With Up to $14 Million in Potential Value

Award builds on a longstanding relationship with CBP and creates a multi-year opportunity to modernize and support the agency’s nationwide simulator network ORLANDO, Fla., Oct. 06, 2026 (GLOBE NEWSWIRE) — VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global leader in immersive, simulation-based training solutions for de-escalation, judgmental use of force and weapons proficiency, today announced that U.S. Customs and Border Protection (CBP) has awarded the Company a sole-source contract to maintain, modernize and support VirTra training systems deployed throughout the agency. The single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract carries a five-year ordering period and a maximum potential value of $14 million and represents an important opportunity for VirTra to build on its established federal customer...

Continue reading

Notice of Additional Buyback Offer for Admiral Markets AS Bonds

Admiral Markets AS (registry code 10932555) is organizing an additional buyback offer for its outstanding Tier 2 bonds issued on 28 December 2017 (ISIN EE3300111251, nominal value EUR 100 per bond, maturity date 28 December 2027, hereinafter the “Bond”) during the period from 8 October 2026 to 29 October 2026 at a price of EUR 103,78 per bond. The value date of the Bond transaction is 2 November 2026 or a date close thereto.  The buyback offer is directed solely to the current bond investors of Admiral Markets AS (hereinafter the “Investor”).  Admiral Markets AS hereby announces an additional buyback offer for its subordinated Bonds. The objective of Admiral Markets AS is to provide all remaining Investors with an opportunity to sell their Bonds to Admiral Markets AS prior to the termination of the listing and trading of the Bonds on the...

Continue reading

Disclosure of total number of voting rights and number of shares in the capital at September 30, 2026

French limited company (Société anonyme) with registered capital of 106,529,962.80 eurosRegistered office: 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisLegal Entity Identifier: 529900JI1GG6F7RKVI53 Disclosure of total number of voting rights and number of sharesin the capital at September 30, 2026 Pursuant to article L-233-8 II of the French “Code de Commerce” and 223-16 of the AMF’s General Regulations:Total number of shares 532,649,827Number of real voting rights (excluding treasury shares) 532,649,827Theoretical number of voting rights (including treasury shares*)(*) pursuant to article 223-11 of the AMF’s General Regulations 532,649,827About L’Oréal For over 115 years, L’Oréal, the world’s leading beauty player, has devoted itself to one thing only: fulfilling the beauty aspirations of consumers around...

Continue reading

Xometry Names Marc Teulières as General Manager for Europe to Accelerate Regional Adoption

Marc Teulières, Xometry Europe General ManagerMarc Teulières joins Xometry as Europe General ManagerKey FactsExecutive Appointment: Marc Teulières appointed General Manager for Xometry Europe. Market Adoption: The appointment targets adoption across European markets, establishing Xometry as the digital infrastructure for custom manufacturing as regional supply chains realign. Proven Track Record: Teulières brings more than 20 years of experience in building enterprise adoption of B2B marketplace models across European industrial markets, including senior leadership positions at Mirakl and McKinsey & Company.MUNICH, Oct. 06, 2026 (GLOBE NEWSWIRE) — Xometry, Inc. (NASDAQ: XMTR), the global, AI-native marketplace connecting buyers and suppliers of custom manufacturing, announced the appointment of enterprise e-commerce...

Continue reading

HI-VIEW RESOURCES COMPLETES 2026 EXPLORATION FIELD PROGRAM IN THE TOODOGGONE MINING DISTRICT, BRITISH COLUMBIA

VANCOUVER, BRITISH COLUMBIA, Oct. 06, 2026 (GLOBE NEWSWIRE) — HI-VIEW RESOURCES INC. (“Hi-View” or the “Company”) (CSE: GXLD; OTCQB: GXLDF; FSE: B630) has completed its 2026 exploration program at their Toodoggone projects in north-central British Columbia. R Nick Horsley, Chief Executive Officer of Hi-View, commented: “Our team delivered an exceptional 2026 program, exceeding both scope and budget with a disciplined, multi-disciplinary approach that integrated geochemical sampling, advanced geophysics, and detailed geological mapping. The work has already generated a suite of compelling geochemical and geophysical anomalies across multiple target areas. While we await final assays and complete interpretation of the geophysical data, our preliminary results are highly encouraging. We are energized by what we’re seeing and look forward...

Continue reading

Gabriel Holding A/S upwardly adjusts its expectations for the financial year 2025/26 for the continuing operations.

As a result of a stronger than expected revenue performance in the continuing operations, Gabriel Holding A/S upgrades its expectations for both revenue and operating profit (EBIT) for the full financial year 2025/26. In the fourth quarter of the financial year, revenue growth in the range of 13% was achieved, exceeding management’s expectations for the quarter. The revenue development during the quarter was driven by growth across all parts of the continuing operations. Based on the preliminary and unaudited financial results, management now expects the following for the financial year just ended, relating to the continuing operations:Revenue in the range of DKK 537-539 million (previously announced guidance: DKK 528-532 million). Operating profit (EBIT) in the range of DKK 50-52 million (previous announced guidance: DKK 44-46 million).In...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.